Phase
Condition
Heart Failure
Chest Pain
Congestive Heart Failure
Treatment
Cordio HearO
Clinical Study ID
Ages > 22 All Genders
Study Summary
Eligibility Criteria
Inclusion
Major inclusion Criteria:
Adults patients
Diagnosed with Symptomatic Chronic Heart Failure [NYHA II-IVa (ambulatory)]
At least one of the following:
One ADHF hospitalization in the last 12 months
One unplanned IV/SC diuretic administration in the last 6 months
Two unplanned IV/SC diuretic administration in the last 12 months
NTProBNP >500 pg/ml or BNP*> 150 pg/ml at screening visit
Clinically stable HF
Willing to participate as evidenced by signing the written informed consent.
Male or non-pregnant female patient (pre-menopausal women will confirm verbally).
Exclusion
Major exclusion Criteria:
Not able to read in Hebrew, Russian, Arabic, English and/or Spanish.
Unable to comply with daily use of the App
Major cardiovascular event
Had a Cardiac Resynchronization Device (CRT) implanted or upgrading ≤ 1 month priorto screening visit.
Has estimated Glomerular Filtration Rate (eGFR) < 30 ml/min/1.73 meter square (Cockroft-Gault formula).
Is likely to undergo heart transplantation/ LVAD within 6 months of Screening Visit.
Study Design
Study Description
Connect with a study center
Barzilai Medical Center- Cardiology
Ashkelon,
IsraelSite Not Available
Heart Failure Clinic - Clallit Be'er Sheva
Be'er Sheva,
IsraelSite Not Available
Rabin Medical Center - Cardiology- CHF
Petah tikva, 49100
IsraelSite Not Available
Kurker Family Medicine
South Windsor, Connecticut 06074
United StatesSite Not Available
C&R Research Services
Cape Coral, Florida 33904
United StatesSite Not Available
C&R Research Services
Miami, Florida 33176
United StatesSite Not Available
Lake County Med Grp
Athens, Georgia 31024
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.